Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
for an Associate Professor position to commence 1st of August 2026. Acute myeloid leukemia (AML) is an aggressive cancer entity with a dismal clinical outcome, due to resistance and relapse in response to current
-
amazing partners, including other Harvard Medical School-affiliated hospitals. Connections working at Dana-Farber Cancer Institute More Jobs from This Employer https://main.hercjobs.org/jobs/22108461/senior
-
Biology The Department of Laboratory Medicine At present, the institute has about 315 employees and approximately 450 million SEK in total assets Subject area Bioinformatics and cancer genetics Subject area
-
). You will be positioned to attract PhD students from the large BBSRC (MIBTP)- MRC- and NERC (CENTA)-funded Doctoral Training Programs at Warwick (https://warwick.ac.uk/fac/sci/lifesci/study/pgr
-
) l'inhibition de GC-C pour pallier le manque d'inhibiteur afin de traiter les maladies diarrhéiques liées à GC-C ou 2) l'activation de GC-C pour cibler le cancer colorectal primaire ou métastatique. En outre, les
-
Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Le cancer du sein demeure la première cause de mortalité
-
https://www.lucc.lu.s e on their respective websites. Responsibilities: Research in immunotechnology with a focus on cancer immunotherapy Teaching at undergraduate, masters, and doctoral level Supervision
-
Position Details Position Information Recruitment/Posting Title Research Scientist III (Trenton) Job Category Staff & Executive - Research (Laboratory/Non-Laboratory) Department CINJ - Cancer
-
about our department, go to http://psychiatry.osu.edu/ . We currently have several open positions to support our growth. While area of specialization is open, we are particularly interested in candidates
-
, immunology, and cancer we use an interdisciplinary approach to mechanistically understand hematopoietic and immune cell identities and translate our findings into novel gene and cell therapies. Immunotherapy